A Novel One-Armed Anti-C-Met Antibody Inhibits Glioblastoma Growth in Vivo

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-1418
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MicroRNA-562 Negatively Regulated C-Met/Akt Pathway in the Growth of Glioblastoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Bevacizumab, an Anti-Vascular Endothelial Growth Factor Antibody, Inhibits Osteoarthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

A Novel Multipurpose Monoclonal Antibody for Evaluating Human C-Met Expression in Preclinical and Clinical Settings

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2009English

ABBV-399, a C-Met Antibody–Drug Conjugate That Targets Both MET –Amplified and C-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

Clinical Cancer Research
Cancer ResearchOncology
2016English

Oncolytic Adenovirus Armed With IL-24 Inhibits the Growth of Breast Cancer in Vitro and in Vivo

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

A Novel Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits Tumor Growth

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Inhibition of EGFR Induces a C-Met-Driven Stem Cell Population in Glioblastoma

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2014English

An Orally Bioavailable C-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

Anti-Cancer Agents in Medicinal Chemistry
Cancer ResearchMolecular MedicinePharmacology
2010English

Novel Antibody-Drug Conjugate With Anti-Cd26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy